Peri̇natal Sonuçlari Beli̇rlemede Msafp Ve Asafp’ni̇n Yeri̇

Abstract

Aim:The aim of our study is to evaluate the effect of maternal serum alpha fetoprotein and amniotic fluid alpha fetoprotein levels on adverse pregnancy outcomes. Materials and Method:In this study, 88 patients who applied to Zekai Tahir Burak Gynecology Training and Research Hospital, who underwent triple screening test and amniocentesis were evaluated. Pregnancy results, maternal serum alpha fetoprotein and amniotic fluid alpha fetoprotein results were analyzed together.Results: There was no correlation between maternal serum alpha fetoprotein and amniotic fluid alpha fetoprotein levels. Although there was a statistically significant relationship between maternal serum alpha fetoprotein level and oligohydramnios, no significant relationship was observed in terms of preeclampsia, preterm labor, ablation placenta risk. No statistically significant relationship was observed between amniotic fluid alpha fetoprotein level and adverse pregnancy outcomes. Conclusion:Maternal serum alpha fetoprotein height, which is included in the triple screening test, has an important significance for oligohydramnios prediction as well as being a marker for neural tube defect. Its relationship with other adverse pregnancy outcomes has not been established.